Immunology and Microbiology
Systemic Lupus Erythematosus
100%
Autoantibodies
29%
Severe Acute Respiratory Syndrome Coronavirus 2
27%
Atherosclerosis
25%
Vaccination Policy
23%
Lupus Erythematosus
20%
Immune-Mediated Inflammatory Diseases
18%
Granulomatosis with Polyangiitis
17%
Monospecific Antibody
17%
Glycation
17%
Autoimmune Disease
13%
Humoral Immunity
11%
interferon
10%
Breakthrough Infection
10%
Nephritis
10%
Raynaud Phenomenon
9%
Autofluorescence
9%
Prevalence
9%
Blood Level
9%
B Cell
8%
Hydroxychloroquine
7%
Immunosuppressive Drug
7%
COVID-19
7%
Vasculitis
7%
CD20
7%
C-Reactive Protein
6%
Vaccine Efficacy
6%
Primary Immunodeficiency
6%
Antiphospholipid Syndrome
6%
Systemic Scleroderma
6%
CD38
6%
Immunoglobulin M
6%
Seroconversion
5%
B Cell Activating Factor
5%
Neutrophil Granulocyte
5%
Common Variable Immunodeficiency
5%
Connective Tissue
5%
Medicine and Dentistry
Systemic Lupus Erythematosus
55%
Antiphospholipid Syndrome
15%
Disease
15%
Atherosclerosis
13%
Intima-Media Thickness
12%
Disease Activity
12%
COVID-19 Vaccination
10%
Inflammatory Disorder
10%
Advanced Glycation End-Product
9%
Autoimmune Disease
8%
Prematurity
7%
Granulomatosis with Polyangiitis
7%
Autoantibodies
7%
Lupus Erythematosus
7%
Venous Thromboembolism
6%
Thermal Burn
6%
Retrospective Cohort Study
6%
Systematic Review
6%
Proteinuria
6%
Capillary Leak Syndrome
5%
Autofluorescence
5%
Clinician
5%
Immunosuppressant
5%
Keyphrases
Systemic Lupus Erythematosus
32%
SRAGE
11%
High Mobility Group Box 1 (HMGB1)
10%
Disease Activity
7%
Systemic Lupus Erythematosus Patient
7%
Autoantibodies
7%
Hydroxychloroquine
6%
Immune-mediated Inflammatory Diseases
6%
Antiphospholipid Syndrome
5%
Healthy Controls
5%
Lupus Nephritis
5%
Raynaud's Phenomenon
5%
COVID-19
5%
Vaccination
5%